Oxford, United Kingdom

Adrian Llewllyn Harris

USPTO Granted Patents = 10 

Average Co-Inventor Count = 2.3

ph-index = 4

Forward Citations = 80(Granted Patents)


Location History:

  • Oxford OX2 64J, GB (1991)
  • Oxford OX2 7NB, GB (2010)
  • Oxford, GB (1999 - 2014)

Company Filing History:


Years Active: 1991-2014

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Adrian Llewllyn Harris: A Pioneer in Tumor Therapy Innovations

Introduction

Adrian Llewllyn Harris is a distinguished inventor based in Oxford, GB, known for his impactful contributions to cancer research. With a portfolio of eight patents to his name, Harris has focused on developing innovative therapeutic methods for enhancing responses to radiation in tumor therapy.

Latest Patents

Among his latest advancements is the patent for "Methods of enhancing the response to radiation in tumor therapy using anti-DLL4 antibodies." This disclosure outlines approaches for treating cancer, tumors, and neoplasias through the administration of ionizing radiation alongside anti-DLL4 antibodies or DLL4-binding fragments. Another significant patent involves the MN gene and protein, where he identified the binding site of the MN protein. This MN protein plays a crucial role in cell adhesion and the formation of intercellular contacts, offering therapeutic targets that could inhibit the growth of preneoplastic/neoplastic vertebrate cells expressing abnormally high levels of MN protein. His innovations also include vectors encoding MN-specific antibodies, which could facilitate targeted therapies against cancer.

Career Highlights

Harris has been affiliated with key organizations that enhance his contributions to the field. Notably, he has worked with Oxford Biomedica (UK) Limited and the Institute of Virology of the Slovak Academy of Sciences, where he has implemented his research findings into practical applications.

Collaborations

Throughout his career, Harris has collaborated with esteemed colleagues such as Peter John Ratcliffe and John David Firth. These partnerships have allowed for the synergistic exchange of ideas, propelling advancements in therapeutic methods targeting cancer treatment.

Conclusion

Adrian Llewllyn Harris stands as a notable figure in the world of cancer research and innovation. His patents not only showcase his inventiveness but also the potential to significantly impact therapeutic approaches for tumor therapies. With ongoing research and significant collaborations, Harris continues to pave the way for future advancements in this critical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…